Global strategic partnerships in regenerative medicine

Trends in Biotechnology

Volumn 32, Issue 9, 2014, Pages 436-440

  French, Anna ^a   Suh, Jane Y ^b   Suh, Carol Y ^c   Rubin, Lee ^b,d   Barker, Richard ^a   Bure, Kim ^e   Reeve, Brock ^d   Brindley, David A ^a,d,f,g  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b Harvard University   (United States)

^c YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d HARVARD STEM CELL INSTITUTE   (United States)

^e SARTORIUS STEDIM BIOTECH GMBH   (Germany)

^f UNIVERSITY OF OXFORD   (United Kingdom)

^g UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

Cell therapies; Regenerative medicine; Stem cells; Strategic partnerships; Translation

Indexed keywords

DRUG INDUSTRY; NOTE; PRIORITY JOURNAL; PUBLIC-PRIVATE PARTNERSHIP; REGENERATIVE MEDICINE; COOPERATION; ORGANIZATION AND MANAGEMENT; PROCEDURES; RESEARCH; TRENDS; UNIVERSITY;

COOPERATIVE BEHAVIOR; DRUG INDUSTRY; PUBLIC-PRIVATE SECTOR PARTNERSHIPS; REGENERATIVE MEDICINE; RESEARCH; UNIVERSITIES;

EID: 84906235975     PISSN: 01677799     EISSN: 18793096     Source Type: Journal    
DOI: 10.1016/j.tibtech.2014.05.007     Document Type: Note

References (10)

1. French A., et al. Commercialization of regenerative medicine: learning from spin-outs. Rejuvenation Res. 2013, 16:164-170.
2. Mason C., et al. Cell therapy industry: billion dollar global business with unlimited potential. Regen. Med. 2011, 6:265-272.
3. Giebel L.B. Stem cells: a hard sell to investors. Nat. Biotechnol. 2005, 23:798-800.
4. Rao M.S. Funding translational work in cell-based therapy. Cell Stem Cell 2011, 9:7-10.
5. Foley L., Whitaker M. Concise review: cell therapies: the route to widespread adoption. Stem Cells Transl. Med. 2012, 1:438-447.
6. Rao M. Public private partnerships: a marriage of necessity. Cell Stem Cell 2013, 12:149-151.
7. Melese T., et al. Open innovation networks between academia and industry: an imperative for breakthrough therapies. Nat. Med. 2009, 15:502-507.
8. Huggett B. Academic-industry partnerships 2012. Nat. Biotechnol. 2013, 31:383.
9. Berggren R., et al. Outlook for the next 5 years in drug innovation. Nat. Rev. Drug Discov. 2012, 11:435-436.
10. Dasgupta I., et al. Patients' attitudes toward the donation of biological materials for the derivation of induced pluripotent stem cells. Cell Stem Cell 2014, 14:9-12.